title: Factors associated with clinical outcome in 25 patients with avian influenza A (H7N9) infection in Guangzhou, China.
abstract: BACKGROUND
  Guangzhou reported its first laboratory-confirmed case of influenza A (H7N9) on January 10, 2014. A total of 25 cases were reported from the first wave of the epidemic until April 8, 2014. The fatality rate was much higher than in previous reports. The objective of the current work was to describe the clinical and epidemiological characteristics of A (H7N9) patients in Guangzhou and explore possible reasons for the high fatality rate.
  
  
  METHODS
  Clinical and epidemiological information regarding A (H7N9) cases in Guangzhou was collected through review of medical records and field research. Data regarding clinical and laboratory features, treatment, and outcomes were extracted.
  
  
  RESULTS
  Of the 25 patients, 84 % (21/25) had one or more underlying diseases. Fifteen patients (60.0 %) developed moderate to severe acute respiratory distress syndrome (ARDS), and 14 (56 %) died of the ARDS or multiorgan failure. Patients with longer delay between onset of illness and initiation of oseltamivir treatment were more likely to develop ARDS. Elevated C-creative protein, aspartate aminotransferase, creatine kinase, and lymphocytopenia predicted a higher risk of developing ARDS.
  
  
  CONCLUSIONS
  The presence of underlying diseases and clinical complications predicted poor clinical outcome. Early oseltamivir treatment was associated with a reduced risk of developing ARDS.
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Wang
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: XinCai
authors.initials: X
authors.lastname: Xiao
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Jianyun
authors.initials: J
authors.lastname: Lu
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Zongqiu
authors.initials: Z
authors.lastname: Chen
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Kuibiao
authors.initials: K
authors.lastname: Li
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Liu
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Luo
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China.
authors.forename: Ming
authors.initials: M
authors.lastname: Wang
authors.affiliation: Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China. Huiwang8451@yahoo.cn.
authors.forename: ZhiCong
authors.initials: Z
authors.lastname: Yang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D005260:Female; D006801:Humans; D064766:Influenza A Virus, H7N9 Subtype / Q000472:pathogenicity*; D007251:Influenza, Human / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D053139:Oseltamivir / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D012189:Retrospective Studies; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir
keywords: Avian influenza; Clinical characteristic; H7N9 subtype